Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
59,400
-1,300 (-2.14%)
At close: Apr 29, 2026

Next Biomedical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Cash & Equivalents
6,7894,9503,9023,01422,016
Upgrade
Short-Term Investments
9,30520,76610,38811,783-
Upgrade
Trading Asset Securities
20,90415,892---
Upgrade
Cash & Short-Term Investments
36,99841,60914,29014,79722,016
Upgrade
Cash Growth
-11.08%191.17%-3.43%-32.79%226.66%
Upgrade
Accounts Receivable
2,2361,845918.64314.3118.67
Upgrade
Other Receivables
92.97321.39214.28170.8486.52
Upgrade
Receivables
2,3292,1671,133485.15205.19
Upgrade
Inventory
3,0362,5812,1691,9401,313
Upgrade
Prepaid Expenses
247.28190.08155.85207.32138.44
Upgrade
Other Current Assets
657.75341.35220.790.865.69
Upgrade
Total Current Assets
43,26746,88817,96817,52123,739
Upgrade
Property, Plant & Equipment
14,01811,27011,42811,73511,918
Upgrade
Long-Term Investments
907.78--2,6373,737
Upgrade
Other Intangible Assets
310.64344.38217.63222.19288.71
Upgrade
Long-Term Accounts Receivable
-0-0-0-0-0
Upgrade
Other Long-Term Assets
761.06342.7529.4821.3537.51
Upgrade
Total Assets
59,26558,84429,64332,13639,720
Upgrade
Accounts Payable
47.6913.3758.1645.024.1
Upgrade
Accrued Expenses
179.5126.23121.14106.9396.48
Upgrade
Short-Term Debt
2,1605,6005,6005,6005,600
Upgrade
Current Portion of Long-Term Debt
4,4934,5394,8974,8005,200
Upgrade
Current Portion of Leases
39.8426.3741.5135.632.24
Upgrade
Other Current Liabilities
1,1241,579714.37452.972,115
Upgrade
Total Current Liabilities
8,04411,88411,43311,04113,048
Upgrade
Long-Term Debt
950.66763.5933.5450020,873
Upgrade
Long-Term Leases
68.4920.5846.981.6346.55
Upgrade
Pension & Post-Retirement Benefits
944.49749.44559.45471.1385.02
Upgrade
Other Long-Term Liabilities
1,151235.35218.84368.8284.7
Upgrade
Total Liabilities
11,15813,65313,19112,46234,636
Upgrade
Common Stock
4,1024,0433,1743,1103,105
Upgrade
Additional Paid-In Capital
111,130107,23461,63260,67960,603
Upgrade
Retained Earnings
-70,597-70,181-72,984-65,367-59,673
Upgrade
Comprehensive Income & Other
3,4724,0952,2771,3241,049
Upgrade
Total Common Equity
48,10745,191-5,901-253.845,084
Upgrade
Shareholders' Equity
48,10745,19116,45219,6745,084
Upgrade
Total Liabilities & Equity
59,26558,84429,64332,13639,720
Upgrade
Total Debt
7,71210,94911,51911,01731,751
Upgrade
Net Cash (Debt)
29,28630,6592,7713,780-9,735
Upgrade
Net Cash Growth
-4.48%1006.61%-26.70%--
Upgrade
Net Cash Per Share
3577.364256.48441.28608.67-2011.96
Upgrade
Filing Date Shares Outstanding
8.428.096.286.214.84
Upgrade
Total Common Shares Outstanding
8.428.096.286.214.84
Upgrade
Working Capital
35,22435,0046,5366,48010,691
Upgrade
Book Value Per Share
5716.705588.37-939.89-40.881050.64
Upgrade
Tangible Book Value
47,79644,847-6,119-476.034,795
Upgrade
Tangible Book Value Per Share
5679.795545.78-974.55-76.65990.97
Upgrade
Land
5,6185,2775,2775,2775,277
Upgrade
Buildings
7,3165,7865,7865,7865,786
Upgrade
Machinery
2,5661,5981,4301,3971,504
Upgrade
Construction In Progress
215.3799.29119.06150.11188.87
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.